HAVCR2 and hepatocellular carcinoma: Importantly, this study declaimed that IGF2BP3 might participate in immune modulation processes, by interacting with immune infiltration (especially myeloid dendritic cell) and immune checkpoints (PDCD1 and HAVCR2) in HCC patients.